APG Asset Management
WST icon

APG Asset Management’s West Pharmaceutical WST Stock Holding History

APG Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$176M Sell
560,582
-706,700
-56% -$216M 0.43% 50
2026
Q1 		$276M Buy
1,267,282
+68,277
+6% +$17M 0.87% 21
2025
Q4 		$281M Sell
1,199,005
-214,693
-15% -$58.7M 0.8% 19
2025
Q3 		$316M Sell
1,413,698
-244,966
-15% -$59.5M 0.89% 16
2025
Q2 		$309M Buy
1,658,664
+96,525
+6% +$20.6M 0.92% 20
2025
Q1 		$324M Buy
1,562,139
+124,737
+9% +$34.4M 1% 21
2024
Q4 		$455M Sell
1,437,402
-871,445
-38% -$274M 1.27% 10
2024
Q3 		$621M Sell
2,308,847
-24,190
-1% -$7.41M 4.12% 5
2024
Q2 		$717M Sell
2,333,037
-4,661
-0.2% -$1.65M 1.28% 14
2024
Q1 		$857M Buy
2,337,698
+37,329
+2% +$13.8M 1.5% 8
2023
Q4 		$733M Buy
2,300,369
+193,452
+9% +$68.5M 1.43% 9
2023
Q3 		$791M Sell
2,106,917
-153,072
-7% -$59.2M 1.62% 6
2023
Q2 		$792M Sell
2,259,989
-125,292
-5% -$44.8M 1.6% 6
2023
Q1 		$761M Sell
2,385,281
-175,552
-7% -$51.3M 1.61% 4
2022
Q4 		$603M Buy
2,560,833
+243,363
+11% +$57.7M 1.15% 12
2022
Q3 		$582M Sell
2,317,470
-84,099
-4% -$25.6M 1.5% 9
2022
Q2 		$695M Sell
2,401,569
-137,599
-5% -$44.8M 1.63% 5
2022
Q1 		$937M Sell
2,539,168
-8,200
-0.3% -$3.21M 1.77% 5
2021
Q4 		$1.05B Buy
2,547,368
+7,500
+0.3% +$3.23M 1.78% 4
2021
Q3 		$930M Buy
2,539,868
+8,500
+0.3% +$3.58M 1.65% 4
2021
Q2 		$767M Buy
2,531,368
+190,900
+8% +$63.1M 1.3% 4
2021
Q1 		$561M Buy
2,340,468
+1,149,862
+97% +$329M 0.96% 14
2020
Q4 		$276M Buy
1,190,606
+680,085
+133% +$191M 0.45% 47
2020
Q3 		$120M Buy
510,521
+257,890
+102% +$68.2M 0.21% 128
2020
Q2 		$51.1M Buy
252,631
+67,440
+36% +$13.3M 0.09% 225
2020
Q1 		$28.2M Buy
185,191
+36,198
+24% +$5.57M 0.06% 330
2019
Q4 		$20M Buy
+148,993
New +$21.7M 0.03% 433

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

APG Asset Management's WST Position: Q2 2026 in Review

APG Asset Management reduced its West Pharmaceutical (WST) stake by 56% in Q2 2026, selling an estimated $216M and leaving 560,582 shares worth $176M. The position accounts for 0.43% of the portfolio, ranked #50.

APG Asset Management first reported a position in WST in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.05B in Q4 2021. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • APG Asset Management held 560,582 shares of West Pharmaceutical worth $176M as of Q2 2026.
  • APG Asset Management sold 706,700 West Pharmaceutical shares in Q2 2026, an estimated $216M.
  • West Pharmaceutical made up 0.43% of APG Asset Management's portfolio in Q2 2026, its #50 holding.
  • APG Asset Management first reported a position in West Pharmaceutical in Q4 2019 and has held it in 27 quarters since.
  • APG Asset Management's West Pharmaceutical position peaked at $1.05B in Q4 2021.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on APG Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.